Cuba remains to this day without any case of COVID-19, which has already spread to 73 countries with more than 90,850 people infected worldwide, of which more than 3,100 have died.
The use of HeberFeron, a drug created and produced by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym), in Havana, has spread throughout the country by opening more centers in different municipalities.
The state-owned company BioCubaFarma has among its priorities the search and development of novel medicines that act differently from those already existing for the therapy of a certain disease.
Based on the morbidity and mortality from abdominal tumors in children, Dr. Yurieenk Cordoves Almaguer, a specialist in pediatric surgery, conceived a protocol to investigate abdominal tumors in pediatric age.